Minimal 16Q Genomic Loss Implicates Cadherin-11 in Retinoblastoma

Total Page:16

File Type:pdf, Size:1020Kb

Minimal 16Q Genomic Loss Implicates Cadherin-11 in Retinoblastoma Minimal 16q Genomic Loss Implicates Cadherin-11 in Retinoblastoma Mellone N. Marchong,1,2 Danian Chen,1,6 Timothy W. Corson,1,3 Cheong Lee,1 Maria Harmandayan,1 Ella Bowles,1 Ning Chen,5 and Brenda L. Gallie1,2,3,4,5 1Divisions of Cancer Informatics and Cellular and Molecular Biology, Ontario Cancer Institute/Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada; Departments of 2Medical Biophysics, 3Molecular and Medical Genetics, and 4Ophthalmology, University of Toronto, Toronto, Ontario, Canada; 5Retinoblastoma Solutions, Toronto, Ontario, Canada; and 6Department of Ophthalmology, West China Hospital, Faculty of Medicine, Sichuan University, Chengdu, People’s Republic of China Abstract compared with normal adult human retina. Our analyses Retinoblastoma is initiated by loss of both RB1 alleles. implicate CDH11, but not CDH13, as a potential tumor Previous studies have shown that retinoblastoma suppressor gene in retinoblastoma. (Mol Cancer Res tumors also show further genomic gains and losses. We 2004;2(9):495–503) now define a 2.62 Mbp minimal region of genomic loss of chromosome 16q22, which is likely to contain tumor suppressor gene(s), in 76 retinoblastoma tumors, using Introduction loss of heterozygosity (30 of 76 tumors) and quantitative Retinoblastoma is the most common intraocular tumor in multiplex PCR (71 of 76 tumors). The sequence-tagged children. Mutations of both alleles (M1 and M2) of the RB1 site WI-5835 within intron 2 of the cadherin-11 (CDH11) gene at chromosome 13q14 are necessary (1) for retinoblastoma gene showed the highest frequency of loss (54%, 22 of tumor initiation but not sufficient for malignant transformation 41 samples tested). A second hotspot for loss (39%, 9 (2). G-banding analysis of retinoblastoma shows that addi- of 23 samples tested) was detected within intron 2 of tional chromosomal aberrations (3) always accompany RB1 À/À the cadherin-13 (CDH13) gene. Furthermore, deletion mutations. Moreover, RB1 murine retina does not sponta- of the exons of CDH11 and/or WI-5835 was shown by neously form retinoblastoma (4) unless one of the pRB-related quantitative multiplex PCR in 17 of 30 (57%) of previously proteins, p107 (5) or p130 (6), is also deleted. We hypothesize untested tumors. Immunoblot analyses revealed that that additional mutational events (M3 to Mn) are required for À/À 91% (20 of 22) retinoblastoma exhibited either a complete RB1 cells to progress into a fully malignant tumor (2). loss or a decrease of the intact form of CDH11 and 8 of To identify these mutational events, we have previously 13 showed a prevalent band suggestive of the variant analyzed chromosomal alterations in 50 retinoblastoma tumors form. Copy number of WI-5835 for these samples by comparative genomic hybridization (CGH) analysis (7). correlated with CDH11 protein expression. CDH11 The minimal region most frequently lost was detected at 16q22 staining was evident in the inner nuclear layer in early (14%; ref. 7). Cumulatively, 51 of 162 (31%) tumors in five mouse retinal development and in small transgenic different CGH studies showed a common region of loss at murine SV40 large T antigen–induced retinoblastoma 16q22 (7-11) as summarized in Fig. 1A. Allelic loss on 16q22 tumors, but advanced tumors frequently showed loss has also been frequently shown in liver (12), breast (13), pros- of CDH11 expression by reverse transcription-PCR, tate (14), and Wilms’ (15) tumors, suggesting the presence suggestive of a role for CDH11 in tumor progression or of important tumor suppressor gene(s) in this chromosomal metastasis. CDH13 protein and mRNA were consistently region. expressed in all human and murine retinoblastoma A cluster of cadherin genes is located at 16q22. Cadherins are calcium-dependent cell-cell adhesion molecules that play crucial roles in formation of gap junctions, in tissue morpho- genesis, and that have been implicated in cancer progression. Received 1/12/04; revised 7/14/04; accepted 7/19/04. For instance, epithelial cadherin (CDH1) has been documented Grant support: Vision Science Research Program of the University of Toronto as a tumor suppressor in a variety of carcinomas (16-21). Given (M.N. Marchong and T.W. Corson), Helen Keller Foundation for Research and Education (D. Chen), National Cancer Institute of Canada with funds from the the role of cadherins as regulators of cell adhesion and their Terry Fox Run and the Canadian Cancer Society (B.L. Gallie), Canadian Genetics apparent loss in a variety of cancers, it seems plausible that there Disease Network (B.L. Gallie), Canadian Institutes for Health Research (B.L. exists a role for cadherins in cancer progression. Gallie), Royal Arch Masons of Canada, Keene Annual Perennial Plant Sale, and Jeff Healy Christmas Concert. Detection of chromosomal loss using CGH has a limit of The costs of publication of this article were defrayed in part by the payment of resolution of f10 to 20 Mbp (22). We have been able to narrow page charges. This article must therefore be hereby marked advertisement in the limit of resolution to the level of single candidate tumor accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Requests for reprints: Brenda L. Gallie, Division of Cancer Informatics, Room suppressor genes by combining loss of heterozygosity (LOH) 8-415, Ontario Cancer Institute/Princess Margaret Hospital, University Health analysis with quantitative multiplex PCR (QM-PCR). Two Network, 610 University Avenue, Toronto, Ontario, Canada M5G 2M9. Phone: 416-946-2324; Fax: 416-946-4619. E-mail: [email protected] candidate tumor suppressor genes, cadherin-11 (CDH11) and Copyright D 2004 American Association for Cancer Research. cadherin-13 (CDH13), emerged from a study of retinoblastoma Mol Cancer Res 2004;2(9). September 2004 495 Downloaded from mcr.aacrjournals.org on September 28, 2021. © 2004 American Association for Cancer Research. 496 Marchong et al. FIGURE 1. Loss of 16q22 in retinoblastoma. A. Loss of the long arm of chromosome 16, or even the entire chromosome, has been observed in five CGH studies of retinoblastoma (7, 8, 9, 10, and 11). Vertical bars to the left of the chromosome ideogram, region of loss in an individual tumor; vertical bars to the right of the chromosome ideogram, region of gain in an individual tumor. Cumulatively, 51 of 162 (31%) of tumors show loss of part or all of 16q, with a minimal common region of loss evident at 16q22 (dotted boxed region). B. Three regions of chromosome 16q allelic loss were defined in retinoblastoma. The percentage of tumors showing allelic loss is plotted against the distance (Mbp) of each marker from the 16p telomere. White bars, microsatellite polymorphic markers assayed for LOH; black bars, STS markers assayed by QM-PCR, with the STS name in italics. For each marker, the number and percentage of tumors showing loss compared with the number tested are indicated; the three hotspots are boxed. The region spanning 2.62 Mbp between STS WI-5835 and flanking markers was lost in 54% of retinoblastoma but, based on data for flanking markers, is consistent with loss in 59% of retinoblastoma (hatched bars). The approximate locations of the cadherin genes that cluster in 16q22-24 are indicated (CDH8, CDH11, CDH5, CDH16, CDH3, CDH1, CDH13). C. Schematic representation of the minimal region of loss, 2.62 Mbp, in which the most frequently lost marker, WI-5835 (59% loss), is located within intron 2 of the CDH11 gene. The two other predicted genes in the area are LOC390735, almost 1 Mbp away from CDH11, and LOC283867, which extends beyond the minimal region of loss. Markers D16S186 and SHGC-140394 that surround the hotspot marker showed only 19% and 27% loss, respectively. tumors. Expression studies in both human retinoblastoma and was analyzed in 41 retinoblastoma DNA samples by QM-PCR the TAg-RB transgenic murine model of retinoblastoma (mice (Fig. 1B). Sixty-eight percent (28 of 41) of the tumors showed expressing SV40 large T antigen in the retina) are consistent allelic loss (copy number V 1.2) of at least one of the five with a tumor suppressor gene role for CDH11 in retinoblastoma, markers. We have extensively applied QM-PCR technology to but CDH13 is excluded as a candidate tumor suppressor gene in the detection of exon copy number of RB1 in clinical tests for retinoblastoma. retinoblastoma families, in which we show that QM-PCR dis- tinguishes correctly between samples that have two, one, or no allele with 97.5% accuracy (23). We optimized the con- Results ditions for QM-PCR for five 16q22 STS markers in four sepa- Chromosome 16q Allelic Loss in Retinoblastoma rate runs. With nontumor DNA set to two copies, the one-copy To define the minimal region of loss at 16q in retinoblas- control (RB264) gave a calculated copy number for all 16q STS toma, 30 pairs of normal/tumor DNA were tested for LOH at loci of 0.78 F 0.22 (mean F SD). The frequency of allelic loss seven microsatellite markers spanning 16q21-23.3, which were for each locus varied from 19% to 54% in 41 tumors (Fig. 1B). heterozygous and therefore informative in a mean of 85% Marker WI-5835 (corresponding to position 16q22.1) showed (ranging from 59% for D16S496 to 100% for D16S514) of the highest frequency of loss (54%, 22 of 41). However, when the retinoblastoma patients. Of the 30 samples, 16 (53%) dis- the data from all markers in individual tumors were examined, played LOH for at least one of the seven markers analyzed it was evident that an additional five tumors not tested with (Fig. 1B). During these LOH studies, microsatellite instability WI-5835 showed a pattern of loss at adjacent markers, consis- (novel fragments in PCR products of tumor DNA compared tent with WI-5835 also being lost, so we might interpolate that with reference DNA) was observed for only two of the seven 59% (27 of 46) of tumors showed allelic loss for this marker microsatellite markers in only 3 of 210 (1.4%) assays.
Recommended publications
  • New CDH3 Mutation in the First Spanish Case of Hypotrichosis with Juvenile Macular Dystrophy, a Case Report
    Blanco-Kelly et al. BMC Medical Genetics (2017) 18:1 DOI 10.1186/s12881-016-0364-5 CASEREPORT Open Access New CDH3 mutation in the first Spanish case of hypotrichosis with juvenile macular dystrophy, a case report Fiona Blanco-Kelly1,2, Luciana Rodrigues-Jacy da Silva1, Iker Sanchez-Navarro1, Rosa Riveiro-Alvarez1,2, Miguel Angel Lopez-Martinez1, Marta Corton1,2 and Carmen Ayuso1,2,3* Abstract Background: CDH3 on 16q22.1 is responsible for two rare autosomal recessive disorders with hypotrichosis and progressive macular dystrophy: Hypotrichosis with Juvenile Macular Dystrophy and Ectodermal Dysplasia, Ectrodactyly and Macular Dystrophy. We present a new case of Hypotrichosis with Juvenile Macular Dystrophy. Case presentation: A Spanish male born in 1998 from non-consanguineous healthy parents with a suspected diagnosis of Keratosis Follicularis Spinulosa Decalvans and Retinitis Pigmentosa Inversa referred to our Genetics Department (IIS-Fundación Jiménez Díaz). Molecular study of ABCA4 was performed, and a heterozygous missense p.Val2050Leu variant in ABCA4 was found. Clinical revision reclassified this patient as Hypotrichosis with Juvenile Macular Dystrophy. Therefore, further CDH3 sequencing was performed showing a novel maternal missense change p.Val205Met (probably pathogenic by in silico analysis), and a previously reported paternal frameshift c.830del;p.Gly277Alafs*20, thus supporting the clinical diagnosis.. Conclusions: This is not only the first Spanish case with this clinical and molecular diagnosis, but a new mutation has been described in CDH3. Moreover, this work reflects the importance of joint assessment of clinical signs and evaluation of pedigree for a correct genetic study approach and diagnostic. Keywords: Macular dystrophy, CDH3, Hypotrichosis, Syndromic retinal dystrophy, Case report Background Dysplasia, Ectrodactyly and Macular Dystrophy (EEM, The CDH3 gene, on16q22.1, encodes for P-cadherin, OMIM: 225280) [18].
    [Show full text]
  • Propranolol-Mediated Attenuation of MMP-9 Excretion in Infants with Hemangiomas
    Supplementary Online Content Thaivalappil S, Bauman N, Saieg A, Movius E, Brown KJ, Preciado D. Propranolol-mediated attenuation of MMP-9 excretion in infants with hemangiomas. JAMA Otolaryngol Head Neck Surg. doi:10.1001/jamaoto.2013.4773 eTable. List of All of the Proteins Identified by Proteomics This supplementary material has been provided by the authors to give readers additional information about their work. © 2013 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 10/01/2021 eTable. List of All of the Proteins Identified by Proteomics Protein Name Prop 12 mo/4 Pred 12 mo/4 Δ Prop to Pred mo mo Myeloperoxidase OS=Homo sapiens GN=MPO 26.00 143.00 ‐117.00 Lactotransferrin OS=Homo sapiens GN=LTF 114.00 205.50 ‐91.50 Matrix metalloproteinase‐9 OS=Homo sapiens GN=MMP9 5.00 36.00 ‐31.00 Neutrophil elastase OS=Homo sapiens GN=ELANE 24.00 48.00 ‐24.00 Bleomycin hydrolase OS=Homo sapiens GN=BLMH 3.00 25.00 ‐22.00 CAP7_HUMAN Azurocidin OS=Homo sapiens GN=AZU1 PE=1 SV=3 4.00 26.00 ‐22.00 S10A8_HUMAN Protein S100‐A8 OS=Homo sapiens GN=S100A8 PE=1 14.67 30.50 ‐15.83 SV=1 IL1F9_HUMAN Interleukin‐1 family member 9 OS=Homo sapiens 1.00 15.00 ‐14.00 GN=IL1F9 PE=1 SV=1 MUC5B_HUMAN Mucin‐5B OS=Homo sapiens GN=MUC5B PE=1 SV=3 2.00 14.00 ‐12.00 MUC4_HUMAN Mucin‐4 OS=Homo sapiens GN=MUC4 PE=1 SV=3 1.00 12.00 ‐11.00 HRG_HUMAN Histidine‐rich glycoprotein OS=Homo sapiens GN=HRG 1.00 12.00 ‐11.00 PE=1 SV=1 TKT_HUMAN Transketolase OS=Homo sapiens GN=TKT PE=1 SV=3 17.00 28.00 ‐11.00 CATG_HUMAN Cathepsin G OS=Homo
    [Show full text]
  • Cadherin 16 (CDH16) Human Gene Knockout Kit (CRISPR) Product Data
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for KN406551 Cadherin 16 (CDH16) Human Gene Knockout Kit (CRISPR) Product data: Product Type: Knockout Kits (CRISPR) Symbol: Cadherin 16 Locus ID: 1014 Kit Components: , 10 ug , 10 ug : EF1a-GFP-P2A-Puro Disclaimer: The kit is designed based on the best knowledge of CRISPR technology. The system has been functionally validated for knocking-in the cassette downstream the native promoter. The efficiency of the knock-out varies due to the nature of the biology and the complexity of the experimental process. RefSeq: NM_001204744, NM_001204745, NM_001204746, NM_004062 Summary: This gene is a member of the cadherin superfamily, genes encoding calcium-dependent, membrane-associated glycoproteins. Mapped to a previously identified cluster of cadherin genes on chromosome 16q22.1, the gene localizes with superfamily members CDH1, CDH3, CDH5, CDH8 and CDH11. The protein consists of an extracellular domain containing 6 cadherin domains, a transmembrane region and a truncated cytoplasmic domain but lacks the prosequence and tripeptide HAV adhesion recognition sequence typical of most classical cadherins. Expression is exclusively in kidney, where the protein functions as the principal mediator of homotypic cellular recognition, playing a role in the morphogenic direction of tissue development. Alternatively spliced transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, Mar 2011] This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2020 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 2 Cadherin 16 (CDH16) Human Gene Knockout Kit (CRISPR) – KN406551 Product images: This product is to be used for laboratory only.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Supplementary Table 1: Adhesion Genes Data Set
    Supplementary Table 1: Adhesion genes data set PROBE Entrez Gene ID Celera Gene ID Gene_Symbol Gene_Name 160832 1 hCG201364.3 A1BG alpha-1-B glycoprotein 223658 1 hCG201364.3 A1BG alpha-1-B glycoprotein 212988 102 hCG40040.3 ADAM10 ADAM metallopeptidase domain 10 133411 4185 hCG28232.2 ADAM11 ADAM metallopeptidase domain 11 110695 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 195222 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 165344 8751 hCG20021.3 ADAM15 ADAM metallopeptidase domain 15 (metargidin) 189065 6868 null ADAM17 ADAM metallopeptidase domain 17 (tumor necrosis factor, alpha, converting enzyme) 108119 8728 hCG15398.4 ADAM19 ADAM metallopeptidase domain 19 (meltrin beta) 117763 8748 hCG20675.3 ADAM20 ADAM metallopeptidase domain 20 126448 8747 hCG1785634.2 ADAM21 ADAM metallopeptidase domain 21 208981 8747 hCG1785634.2|hCG2042897 ADAM21 ADAM metallopeptidase domain 21 180903 53616 hCG17212.4 ADAM22 ADAM metallopeptidase domain 22 177272 8745 hCG1811623.1 ADAM23 ADAM metallopeptidase domain 23 102384 10863 hCG1818505.1 ADAM28 ADAM metallopeptidase domain 28 119968 11086 hCG1786734.2 ADAM29 ADAM metallopeptidase domain 29 205542 11085 hCG1997196.1 ADAM30 ADAM metallopeptidase domain 30 148417 80332 hCG39255.4 ADAM33 ADAM metallopeptidase domain 33 140492 8756 hCG1789002.2 ADAM7 ADAM metallopeptidase domain 7 122603 101 hCG1816947.1 ADAM8 ADAM metallopeptidase domain 8 183965 8754 hCG1996391 ADAM9 ADAM metallopeptidase domain 9 (meltrin gamma) 129974 27299 hCG15447.3 ADAMDEC1 ADAM-like,
    [Show full text]
  • Learning from Cadherin Structures and Sequences: Affinity Determinants and Protein Architecture
    Learning from cadherin structures and sequences: affinity determinants and protein architecture Klára Fels ıvályi Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Graduate School of Arts and Sciences COLUMBIA UNIVERSITY 2014 © 2014 Klara Felsovalyi All rights reserved ABSTRACT Learning from cadherin structures and sequences: affinity determinants and protein architecture Klara Felsovalyi Cadherins are a family of cell-surface proteins mediating adhesion that are important in development and maintenance of tissues. The family is defined by the repeating cadherin domain (EC) in their extracellular region, but they are diverse in terms of protein size, architecture and cellular function. The best-understood subfamily is the type I classical cadherins, which are found in vertebrates and have five EC domains. Among the five different type I classical cadherins, the binding interactions are highly specific in their homo- and heterophilic binding affinities, though their sequences are very similar. As previously shown, E- and N-cadherins, two prototypic members of the subfamily, differ in their homophilic K D by about an order of magnitude, while their heterophilic affinity is intermediate. To examine the source of the binding affinity differences among type I cadherins, we used crystal structures, analytical ultracentrifugation (AUC), surface plasmon resonance (SPR), and electron paramagnetic resonance (EPR) studies. Phylogenetic analysis and binding affinity behavior show that the type I cadherins can be further divided into two subgroups, with E- and N-cadherin representing each. In addition to the affinity differences in their wild-type binding through the strand-swapped interface, a second interface also shows an affinity difference between E- and N-cadherin.
    [Show full text]
  • The Urothelial Cell Line Urotsa Transformed by Arsenite and Cadmium Display Basal Characteristics Associated with Muscle Invasive Urothelial Cancers
    University of North Dakota UND Scholarly Commons Pathology Faculty Publications Department of Pathology 12-14-2018 The Urothelial Cell Line UROtsa Transformed by Arsenite and Cadmium Display Basal Characteristics Associated with Muscle Invasive Urothelial Cancers Zachary E. Hoggarth Danyelle B. Osowski Brooke A. Freeberg Scott H. Garrett University of North Dakota, [email protected] Mary Ann Sens University of North Dakota, [email protected] See next page for additional authors Follow this and additional works at: https://commons.und.edu/path-fac Recommended Citation Hoggarth, Zachary E.; Osowski, Danyelle B.; Freeberg, Brooke A.; Garrett, Scott H.; Sens, Mary Ann; Zhou, Xudong; Zhang, Ke K.; and Somji, Seema, "The Urothelial Cell Line UROtsa Transformed by Arsenite and Cadmium Display Basal Characteristics Associated with Muscle Invasive Urothelial Cancers" (2018). Pathology Faculty Publications. 1. https://commons.und.edu/path-fac/1 This Article is brought to you for free and open access by the Department of Pathology at UND Scholarly Commons. It has been accepted for inclusion in Pathology Faculty Publications by an authorized administrator of UND Scholarly Commons. For more information, please contact [email protected]. Authors Zachary E. Hoggarth, Danyelle B. Osowski, Brooke A. Freeberg, Scott H. Garrett, Mary Ann Sens, Xudong Zhou, Ke K. Zhang, and Seema Somji This article is available at UND Scholarly Commons: https://commons.und.edu/path-fac/1 RESEARCH ARTICLE The urothelial cell line UROtsa transformed by arsenite and cadmium display basal characteristics associated with muscle invasive urothelial cancers Zachary E. Hoggarth, Danyelle B. Osowski, Brooke A. Freeberg, Scott H. Garrett, Donald A.
    [Show full text]
  • Integrative Epigenomic and Genomic Analysis of Malignant Pheochromocytoma
    EXPERIMENTAL and MOLECULAR MEDICINE, Vol. 42, No. 7, 484-502, July 2010 Integrative epigenomic and genomic analysis of malignant pheochromocytoma Johanna Sandgren1,2* Robin Andersson3*, pression examination in a malignant pheochromocy- Alvaro Rada-Iglesias3, Stefan Enroth3, toma sample. The integrated analysis of the tumor ex- Goran̈ Akerstro̊ m̈ 1, Jan P. Dumanski2, pression levels, in relation to normal adrenal medulla, Jan Komorowski3,4, Gunnar Westin1 and indicated that either histone modifications or chromo- somal alterations, or both, have great impact on the ex- Claes Wadelius2,5 pression of a substantial fraction of the genes in the in- vestigated sample. Candidate tumor suppressor 1Department of Surgical Sciences genes identified with decreased expression, a Uppsala University, Uppsala University Hospital H3K27me3 mark and/or in regions of deletion were for SE-75185 Uppsala, Sweden 2 instance TGIF1, DSC3, TNFRSF10B, RASSF2, HOXA9, Department of Genetics and Pathology Rudbeck Laboratory, Uppsala University PTPRE and CDH11. More genes were found with in- SE-75185 Uppsala, Sweden creased expression, a H3K4me3 mark, and/or in re- 3The Linnaeus Centre for Bioinformatics gions of gain. Potential oncogenes detected among Uppsala University those were GNAS, INSM1, DOK5, ETV1, RET, NTRK1, SE-751 24 Uppsala, Sweden IGF2, and the H3K27 trimethylase gene EZH2. Our ap- 4Interdisciplinary Centre for Mathematical and proach to associate histone methylations and DNA Computational Modelling copy number changes to gene expression revealed ap- Warsaw University parent impact on global gene transcription, and en- PL-02-106 Warszawa, Poland abled the identification of candidate tumor genes for 5Corresponding author: Tel, 46-18-471-40-76; further exploration.
    [Show full text]
  • Adherens Junctions, Desmosomes and Tight Junctions in Epidermal Barrier Function Johanna M
    14 The Open Dermatology Journal, 2010, 4, 14-20 Open Access Adherens Junctions, Desmosomes and Tight Junctions in Epidermal Barrier Function Johanna M. Brandner1,§, Marek Haftek*,2,§ and Carien M. Niessen3,§ 1Department of Dermatology and Venerology, University Hospital Hamburg-Eppendorf, Hamburg, Germany 2University of Lyon, EA4169 Normal and Pathological Functions of Skin Barrier, E. Herriot Hospital, Lyon, France 3Department of Dermatology, Center for Molecular Medicine, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Germany Abstract: The skin is an indispensable barrier which protects the body from the uncontrolled loss of water and solutes as well as from chemical and physical assaults and the invasion of pathogens. In recent years several studies have suggested an important role of intercellular junctions for the barrier function of the epidermis. In this review we summarize our knowledge of the impact of adherens junctions, (corneo)-desmosomes and tight junctions on barrier function of the skin. Keywords: Cadherins, catenins, claudins, cell polarity, stratum corneum, skin diseases. INTRODUCTION ADHERENS JUNCTIONS The stratifying epidermis of the skin physically separates Adherens junctions are intercellular structures that couple the organism from its environment and serves as its first line intercellular adhesion to the cytoskeleton thereby creating a of structural and functional defense against dehydration, transcellular network that coordinate the behavior of a chemical substances, physical insults and micro-organisms. population of cells. Adherens junctions are dynamic entities The living cell layers of the epidermis are crucial in the and also function as signal platforms that regulate formation and maintenance of the barrier on two different cytoskeletal dynamics and cell polarity.
    [Show full text]
  • Cadherin-11 Mediates Cancer Hijacking Fibroblasts
    bioRxiv preprint doi: https://doi.org/10.1101/729491; this version posted August 9, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Post-EMT: Cadherin-11 mediates cancer hijacking fibroblasts Weirong Kang1Ϯ, Yibo Fan1Ϯ, Yinxiao Du1Ϯ, Elina A. Tonkova2, Yi-Hsin Hsu3, Kel Vin Tan4, Stephanie Alexander5, Bin Sheng Wong6, Haocheng Yang1, Jingyuan Luo1, Kuo Yao1, Jiayao Yang1, Xin Hu7, Tingting Liu8, Yu Gan8, Jian Zhang9, Jean J. Zhao10,11, Konstantinos Konstantopoulos6, Peter Friedl5, Pek Lan Khong4, Aiping Lu1, Mien-Chie Hung3,12, Michael B. Brenner2, Jeffrey E. Segall13, Zhizhan Gu1,2,6,10,13,# 1Centre for Cancer and Inflammation Research, Institute of Integrated Bioinformedicine and Translational Science, and School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China 2Division of Rheumatology, Immunology, and Allergy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA 3Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center Houston, TX, USA 4Department of Diagnostic Radiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China 5Department of Cell Biology, RIMLS, Radboud University Medical Center, Nijmegen, The Netherlands; David H. Koch Center for Applied Research of Genitourinary Cancers, Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston,
    [Show full text]
  • Coexisting Proinflammatory and Antioxidative Endothelial Transcription Profiles in a Disturbed Flow Region of the Adult Porcine Aorta
    Coexisting proinflammatory and antioxidative endothelial transcription profiles in a disturbed flow region of the adult porcine aorta Anthony G. Passerini*†‡, Denise C. Polacek*‡, Congzhu Shi*, Nadeene M. Francesco*, Elisabetta Manduchi§, Gregory R. Grant§, William F. Pritchard¶, Steven Powellʈ, Gary Y. Chang*†, Christian J. Stoeckert, Jr.§**, and Peter F. Davies*†,††‡‡ *Institute for Medicine and Engineering, Departments of †Bioengineering, ††Pathology and Laboratory Medicine, and **Genetics, and §Center for Bioinformatics, University of Pennsylvania, Philadelphia, PA 19104; ¶U.S. Food and Drug Administration, Rockville, MD 20852; and ʈAstraZeneca Pharmaceuticals, Mereside Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom Edited by Louis J. Ignarro, University of California School of Medicine, Los Angeles, CA, and approved December 22, 2003 (received for review September 15, 2003) In the arterial circulation, regions of disturbed flow (DF), which are with protective profiles of gene expression (e.g., antioxidative, characterized by flow separation and transient vortices, are suscep- antiinflammatory, and͞or antiproliferative) when compared to the tible to atherogenesis, whereas regions of undisturbed laminar flow absence of flow (7–11, 13, 14, 17, 19) and selected examples of the (UF) appear protected. Coordinated regulation of gene expression by protective genes have been shown to be expressed in endothelium endothelial cells (EC) may result in differing regional phenotypes that in vivo (14, 19). A small number of microarray studies comparing either favor or inhibit atherogenesis. Linearly amplified RNA from EC gene expression between DF and UF conditions in vitro have freshly isolated EC of DF (inner aortic arch) and UF (descending been conducted (15, 16); however, transcriptional profiling in vivo thoracic aorta) regions of normal adult pigs was used to profile has been limited by the small sample size available within hemo- differential gene expression reflecting the steady state in vivo.By dynamic regions of interest.
    [Show full text]
  • Chromosomal Microarray Analysis in Turkish Patients with Unexplained Developmental Delay and Intellectual Developmental Disorders
    177 Arch Neuropsychitry 2020;57:177−191 RESEARCH ARTICLE https://doi.org/10.29399/npa.24890 Chromosomal Microarray Analysis in Turkish Patients with Unexplained Developmental Delay and Intellectual Developmental Disorders Hakan GÜRKAN1 , Emine İkbal ATLI1 , Engin ATLI1 , Leyla BOZATLI2 , Mengühan ARAZ ALTAY2 , Sinem YALÇINTEPE1 , Yasemin ÖZEN1 , Damla EKER1 , Çisem AKURUT1 , Selma DEMİR1 , Işık GÖRKER2 1Faculty of Medicine, Department of Medical Genetics, Edirne, Trakya University, Edirne, Turkey 2Faculty of Medicine, Department of Child and Adolescent Psychiatry, Trakya University, Edirne, Turkey ABSTRACT Introduction: Aneuploids, copy number variations (CNVs), and single in 39 (39/123=31.7%) patients. Twelve CNV variant of unknown nucleotide variants in specific genes are the main genetic causes of significance (VUS) (9.75%) patients and 7 CNV benign (5.69%) patients developmental delay (DD) and intellectual disability disorder (IDD). were reported. In 6 patients, one or more pathogenic CNVs were These genetic changes can be detected using chromosome analysis, determined. Therefore, the diagnostic efficiency of CMA was found to chromosomal microarray (CMA), and next-generation DNA sequencing be 31.7% (39/123). techniques. Therefore; In this study, we aimed to investigate the Conclusion: Today, genetic analysis is still not part of the routine in the importance of CMA in determining the genomic etiology of unexplained evaluation of IDD patients who present to psychiatry clinics. A genetic DD and IDD in 123 patients. diagnosis from CMA can eliminate genetic question marks and thus Method: For 123 patients, chromosome analysis, DNA fragment analysis alter the clinical management of patients. Approximately one-third and microarray were performed. Conventional G-band karyotype of the positive CMA findings are clinically intervenable.
    [Show full text]